Table 2 Patient characteristics at admission
|  | HBOx1 group (N = 69) | HBOx2 group (N = 14) | non-HBO group (N = 10) |
|---|---|---|---|
Age | 61 (54 – 68) | 55 (51 – 70) | 58 (53 – 64) |
Sex, male | 48 (70) | 7 (50) | 7 (70) |
BMI (kg/m2) | 26 (23 – 31) | 26 (23 −31) | 25 (23 – 37) |
Comorbidities | |||
 Cardiovascular disease | 38 (55) | 5 (36) | 7 (70) |
 Chronic kidney injury | 5 (7) | 1 (7) | 2 (20) |
 COPD | 7 (10) | 1 (7) | 1 (10) |
 Diabetes (type 1 and 2) | 25 (36) | 4 (28) | 4 (40) |
 Immune deficiently | 3 (4) | 0 | 2 (20) |
 Chronic liver disease | 1 (1.4) | 1 (7) | 2 (20) |
 Malignancy | 3 (4) | 2 (14) | 0 |
 Peripheral vascular disease | 8 (11) | 2 (14) | 1 (10) |
 Rheumatoid disease | 2 (3) | 1 (7) | 1 (10) |
 No comorbidities | 16 (23) | 4 (29) | 3 (30) |
Microbial findings | |||
 Monomicrobial | 29 (42) | 2 (14.3) | 3 (30) |
 Polymicrobial | 32 (46) | 9 (64.3) | 7 (70) |
 Negative | 8 (12) | 3 (21.4) | 0 |
Body-part affected | |||
 Head/neck | 14 (20) | 3 (21.5) | 1 (10) |
 Abdomen/genitals | 32 (46) | 9 (64.5) | 2 (20) |
 Upper extremity | 8 (12) | 1 (7) | 4 (40) |
 Lower extremity | 15 (22) | 1 (7) | 3 (30) |
Paraclinical parameters | |||
 White blood cell count (× 109 /L) | 15 (11–22) | 22 (14–30) | 12 (8–17) |
 Platelet count (× 109 /L) | 195 (127 – 317) | 206 (196 – 316) | 120 (96–218) |
 eGFR (ml.min.per.1.73 m) | 64 (36 – 90) | 47 (21 – 79) | 28 (23 – 42) |
 Creatinine (µmol/l) | 95 (64 – 152) | 96 (82 – 231) | 192 (156 – 243) |
 CRP (mg/L) | 233 (138 – 316) | 246 (200 – 296) | 330 (163–392) |
 Lactate dehydrogenase (U/L) | 186 (154 – 240) | 148 (136 – 183) | 238 (199 – 322) |